| Elevated CXorf67 expression in PFA ependymomas suppresses DNA repair and sensitizes to PARP inhibitors J Han, M Yu, Y Bai, J Yu, F Jin, C Li, R Zeng, J Peng, A Li, X Song, H Li, ... Cancer Cell 38 (6), 844-856. e7, 2020 | 64 | 2020 |
| Pentagalloylglucose disrupts the PALB2-BRCA2 interaction and potentiates tumor sensitivity to PARP inhibitor and radiotherapy J Zeng, J Han, Z Liu, M Yu, H Li, J Yu Cancer Letters 546, 215851, 2022 | 39 | 2022 |
| EZH2 inhibition sensitizes MYC-high medulloblastoma cancers to PARP inhibition by regulating NUPR1-mediated DNA repair J Yu, J Han, M Yu, H Rui, A Sun, H Li Oncogene, 1-15, 2024 | 22 | 2024 |
| Synergistic effect of poly (ADP-ribose) polymerase (PARP) inhibitor with chemotherapy on CXorf67-elevated posterior fossa group A ependymoma J Han, J Yu, M Yu, Y Liu, X Song, H Li, L Li Chinese Medical Journal, 10.1097, 2024 | 7 | 2024 |
| The efficacy of niraparib in pediatric recurrent PFA⁃ type ependymoma LI Lin, LI Hao Chinese Journal of Contemporary Neurology & Neurosurgery 24 (9), 739, 2024 | 1 | 2024 |
| Research progress on the function and mechanism of CXorf67 in PFA ependymoma LL Jichang Han, Xiaomin Song, Yachao Liu CHINESE SCIENCE BULLETIN-CHINESE 67 (33), 3976-3983, 2022 | | 2022 |
Ao LiDepartment of Pharmacology, Yale University School of MedicineVerified email at yale.edu